ABCD3
protein-codingATP binding cassette subfamily D member 3, the group of ATP binding cassette subfamily D|GOLD domain containing
Gene summary
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein likely plays an important role in peroxisome biogenesis. Mutations have been associated with some forms of Zellweger syndrome, a heterogeneous group of peroxisome assembly disorders. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
- PXMP1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~100.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014564
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014564
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0014564
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014564
Submitter: ClinGen
The relationship between *ABCD3* and congenital bile acid synthesis defect 5 (ABCD3 congenital bile acid synthesis defect), an autosomal recessive disorder, was evaluated using the ClinGen Clinical Validity Framework as of April, 2022. *ABCD3* encodes an ATP-binding cassette transporter involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs (also called peroxisomal membrane protein 70, PMP70). Some of the phenotypes associated with ABCD3 congenital bile acid synthesis defect or include hepatomegaly, jaundice and increased plasma bile acid intermediates and VLCFAs. *ABCD3* was first reported in relation to autosomal recessive congenital bile acid synthesis defect in 2015. (Ferdinandusse et al, PMID: 25168382). This is the only report of a genetic defect in *ABCD3* identified in a human patient. Earlier, *ABCD3* was associated with peroxisome biogenesis as mutations were identified in the *ABCD3* gene in patients with Zellweger syndrome. However, it was later shown that a *PEX1* defect was the underlying cause of peroxisome biogenesis disorder in those patients (PMID: 25168382). Summary of Case Level Data (1 point): A homozygous deletion variant has been reported in 1 proband in 1 publication (PMID: 25168382), wherein a truncated protein product is shown to be made. The mechanism for disease is expected to be homozygous loss of function. Summary of experimental data (4 points): This gene-disease association is supported by a mouse models that recapitulate some of the human disease phenotype (PMIDs 25168382, 34564857) and protein interactions with *ABCD1* (PMID: 10551832) and PEX19 (PMID: 16344115). In summary, there is limited evidence to support the gene-disease relationship of *ABCD3* and congenital bile acid synthesis defect 5. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was originally evaluated by the Peroxisomal GCEP on April 27, 2022. It was reevaluated on June 6, 2025 (SOP v 10). No new evidence was added and the classification did not change.
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Craniofacial; Gastrointestinal; Neurologic
Intervention: Gastrointestinal
Rationale: Early interventions, such as with bile replacement therapy, may be beneficial, though liver transplant may be necessary
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ABCD3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002858.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 39 | 2 | 42 | ||
| missense | 111 | 2 | 1 | 114 | ||
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 7 | |||
| Total | 1 | 0 | 124 | 41 | 3 | 169 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002849.1 | 23 | MANE Select | |
| Ensembl | ENSP00000359233.4 | 23 | MANE Select | |
| RefSeq | NP_001116146.1 | 9 | Standard | |
| Ensembl | ENSP00000326880.5 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peroxisome - Homo sapiens (human)
- ABC transporters - Homo sapiens (human)
- Nuclear Receptors in Lipid Metabolism and Toxicity
- ABC transporters in lipid homeostasis
- Transport of small molecules
Biological Process
- fatty acid biosynthetic process
- fatty acid beta-oxidation
- peroxisome organization
- response to organic cyclic compound
- peroxisomal long-chain fatty acid import
Molecular Function
- long-chain fatty acid transporter activity
- protein binding
- ATP binding
- ATPase activity
- ATPase activity, coupled to transmembrane movement of substances
Cellular Component
- mitochondrion
- peroxisome
- peroxisomal membrane
- peroxisomal matrix
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000370214
- Coding exons
- 23
- Length
- 100290
- Individuals with no LoFs
- 125707
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 32
- Defined
- 125739
- p
- 0.000127
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.54 | 229 | 366 | 0.626 | 0.0000195 | 4292 |
| Missense (PolyPhen) | 53 | 139.32 | 0.38041 | 1560 | ||
| Synonymous | 0.821 | 111 | 123 | 0.906 | 0.00000611 | 1233 |
| Loss of Function | 4.75 | 14 | 50.3 | 0.278 | 0.00000312 | 541 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000064 | 0.000062 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00060 | 0.00060 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable transporter involved in the transport of branched-chain fatty acids and C27 bile acids into the peroxisome; the latter function is a crucial step in bile acid biosynthesis (PubMed:25168382). The nucleotide-binding fold acts as an ATP- binding subunit with ATPase activity (PubMed:11248239). {ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:25168382}.;
- Disease
- DISEASE: Congenital bile acid synthesis defect 5 (CBAS5) [MIM:616278]: An autosomal recessive disorder characterized by hepatosplenomegaly, hepatic fibrosis, progressive liver failure, and accumulation of peroxisomal C27-bile acid intermediates in plasma. {ECO:0000269|PubMed:25168382}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.297
Intolerance Scores
- LoFtool
- 0.115
- RVIS EVS
- -0.65
- RVIS percentile EVS
- 16.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.806
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |